Landscapes / Companies
Hangzhou DAC Biotechnology Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
6
in active trials · 5 checked
Trials
7 active
7 since 2021
Drugs6
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 1 Jun 2028Phase 1/2 trial completes | |||
| Next date | 1 Jun 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Hematological Malignancies and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Mar 2029Phase 1 trial completes | |||
| Next date | 31 Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Prostate Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Aug 2029Phase 1 trial completes | |||
| Next date | 31 Aug 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2030Phase 1 trial completes | |||
| Next date | Apr 2030 · Phase 1 trial completes | ||||
| Also tested for | Prostate Cancer, Other Solid Tumors and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 20 Oct 2030Phase 1 trial completes | |||
| Next date | 20 Oct 2030 · Phase 1 trial completes | ||||
| Also tested for | Small Cell Lung Cancer, Melanoma and 2 more | ||||
| Open drug page | |||||
DXC016not checked |
— |
Phase 1 | 1 Dec 2030Phase 1 trial completes | ||
| Next date | 1 Dec 2030 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021